Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/1999
03/23/1999CA1340458C 1, 2, 3-triazole and tetrazole substituted piperidine or tetrahydropyridine compounds useful as acetylcholine agonists
03/22/1999CA2244237A1 A human lig-1 homolog (hlig-1)
03/18/1999WO1999013054A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999WO1999012967A1 Retro-inverso neurotrophic and analgesic peptides
03/18/1999WO1999012961A1 Estrogen receptor
03/18/1999WO1999012930A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999WO1999012926A1 Tetrahydro gamma-carbolines
03/18/1999WO1999012924A1 Piperidinylmethyloxazolidinone derivative
03/18/1999WO1999012915A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999WO1999012908A1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity
03/18/1999WO1999012640A1 Coated particles, methods of making and using
03/18/1999WO1999012560A1 Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors
03/18/1999WO1999012559A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999WO1999012549A2 Controlled release microsphere delivery system
03/18/1999WO1999012529A2 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1998044103A3 Protein for inhibiting apoptosis
03/18/1999DE19740110A1 New hydroxy substituted benzomorphan derivatives
03/18/1999CA2304108A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999CA2302762A1 Controlled release microsphere delivery system
03/18/1999CA2301807A1 Tetrahydro gamma-carbolines
03/18/1999CA2300387A1 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999CA2300221A1 Retro-inverso neurotrophic and analgesic peptides
03/18/1999CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
03/17/1999EP0902027A1 Indole and indazole derivatives, process for their preparation and the pharmaceutical compositions containing them
03/17/1999EP0902018A2 2-(Arylphenyl)amino-imidazoline derivatives
03/17/1999EP0902003A1 Novel tetralone or benzopyranone derivatives and process for producing the same
03/17/1999EP0901789A1 Method of treating tourette's syndrome
03/17/1999EP0901786A2 Solid pharmaceutical dispersions with enhanced bioavailability
03/17/1999EP0901499A1 Adenosine derivatives
03/17/1999EP0901489A1 Antagonists of gonadotropin releasing hormone
03/17/1999EP0901487A1 Novel 2,3 disubstituted-4(3h)-quinazolinones
03/17/1999EP0901483A2 Benzofurans and benzopyrans as chronobiological agents
03/17/1999EP0901482A1 Benzofuran carboxamides and their therapeutic use
03/17/1999EP0901476A1 Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives
03/17/1999EP0901474A1 Aryl pyrimidine derivatives
03/17/1999EP0901473A1 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the novel compounds
03/17/1999EP0901469A1 Arylalkylpiperazine compounds as antioxidants
03/17/1999EP0901376A1 Malatonin in combination with analgesics
03/17/1999EP0901374A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
03/17/1999EP0799231B1 Spiroketal derivatives, compositions containing them and their use as therapeutic agents
03/17/1999EP0789699B1 SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
03/17/1999EP0737070A4 Vitamin d 3? analogues and pathway to mediate disorders
03/17/1999EP0708774B1 IMIDAZO[1,2-a]PYRAZIN-4-ONE DERIVATIVES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
03/17/1999EP0673249B1 Triazoloquinazolines for the treatment of diseases of the central nervous system
03/17/1999EP0626954B1 Benzocycloheptenes, benzoxepines and benzothiepines
03/17/1999EP0565634B1 Angiotensin ii receptor blocking compositions
03/17/1999CN1211254A Fused pyrrolo (2,3-C) carbazole-6-ones which potentiate activity of gamma interferon
03/17/1999CN1211251A 1,4-dihydropyridine compounds as bradykinin antagonists
03/17/1999CN1211190A Natural tea for taking off the effects of drink and process for production thereof
03/17/1999CN1211180A Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity
03/17/1999CN1210864A New medicine for curing presenile dementia and cerebral apoplexy sequelae
03/17/1999CN1210735A 治疗癫痫的药物 Drug treatment of epilepsy
03/17/1999CN1042539C 11,21-bisphenyl-19-norpregnane derivatives
03/17/1999CN1042534C Aroyl urea derivatives or preparing method for additive salts of medicinal acid
03/17/1999CN1042533C Substituted 1-(7-chloroquinolin-4-yl) pyrazole-3-carboxamide N-oxide derivatives, method of preparing them and the pharmaceutical compositions
03/17/1999CN1042531C Method for preparing corbostyril derivatives
03/16/1999US5883294 Selective thyroid hormone analogs
03/16/1999US5883257 N-piperidinyl- and N-tetrahydropyridinyl-2-anthracenecarboxamides: dopamine receptor subtype specific ligands
03/16/1999US5883251 Enzyme inhibitors
03/16/1999US5883137 Compositions and methods for the control of smoking
03/16/1999US5883129 Hydroxylated anthranilic acid derivatives
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883122 Neuroprotective agents
03/16/1999US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/16/1999US5883114 Indolocarbazole imides and the use thereof
03/16/1999US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis
03/16/1999US5883111 Heterocyclic compounds and their use as angiotensin antagonists
03/16/1999US5883096 Di-n-substituted piperazine derivatives; alzheimer*s disease, cognition activators; synergistic mixtures with acetylcholinesterase inhibitors
03/16/1999US5882944 Methods for G protein coupled receptor activity screening
03/16/1999US5882674 Transdermal therapeutic system comprising active substances representing carbon monoxide sources
03/16/1999US5882671 Using an agonist which acts at negatively coupled camp-linked metabotropic glutamate receptors
03/16/1999US5882656 Useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, paget's disease, malignant hypercalcemia, and
03/16/1999CA2167198C Benzylaminoquinuclidines
03/16/1999CA2158108C Compositions containing sertraline and a 5-ht1d receptor agonist or antagonist
03/16/1999CA2150709C Pyrazolopyrimidines
03/16/1999CA2058264C Dihydrobenzofuran carboxamides and process for their preparation
03/16/1999CA1340444C Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents
03/11/1999WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/11/1999WO1999011647A1 Fused thiophene compounds and medicinal use thereof
03/11/1999WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999WO1999011643A1 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
03/11/1999WO1999011628A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/11/1999WO1999011620A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
03/11/1999WO1999011605A1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
03/11/1999WO1999011283A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999WO1999011274A1 Use of purine nucleosides for modulating the axonal outgrowth of central nervous system neurons
03/11/1999WO1999011264A1 Il-8 receptor antagonists
03/11/1999WO1999011257A1 Improved compositions and methods for the control of smoking
03/11/1999WO1999011253A1 Il-8 receptor antagonists
03/11/1999WO1999011252A2 N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain
03/11/1999WO1998057984A3 Torsin, torsin genes, and methods of use
03/11/1999DE19738855A1 Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht Transdermal therapeutic system with contact adhesive reservoir layer and unidirectional elastic backing
03/11/1999CA2303815A1 N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain
03/11/1999CA2303280A1 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
03/11/1999CA2302450A1 Il-8 receptor antagonists
03/11/1999CA2302409A1 Condensed thiophene compounds and pharmaceutical use thereof
03/11/1999CA2302364A1 Il-8 receptor antagonists
1 ... 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 ... 1833